Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH (2023) The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol 949:175586. https://doi.org/10.1016/j.ejphar.2023.175586

Article  CAS  PubMed  Google Scholar 

Goswami AG, Basu S, Huda F et al (2022) An appraisal of vascular endothelial growth factor (VEGF): The dynamic molecule of wound healing and its current clinical applications. Growth Fact 40(3–4):73–88. https://doi.org/10.1080/08977194.2022.2074843

Article  CAS  Google Scholar 

Zhang B, Wang D, Ji TF, Shi L, Yu JL (2017) Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model. Oncotarget 8(10):17347

Article  PubMed  Google Scholar 

Dabravolski SA, Khotina VA, Omelchenko AV, Kalmykov VA, Orekhov AN (2022) The role of the VEGF family in atherosclerosis development and its potential as treatment targets. Int J Mol Sci 23(2):931. https://doi.org/10.3390/ijms23020931

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Li Y, Wang Y et al (2022) Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J Hematol Oncol 15(1):1–28. https://doi.org/10.1186/s13045-022-01310-7

Article  CAS  Google Scholar 

Le THV, Kwon SM (2022) Vascular endothelial growth factor biology and its potential as a therapeutic target in rheumatic diseases. Int J Mol Sci 22(10):5387. https://doi.org/10.3390/ijms22105387

Article  CAS  Google Scholar 

Belvedere R, Novizio N, Morello S, Petrella A (2022) The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk. Sci Rep 12(1):11041. https://doi.org/10.1038/s41598-022-15227-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shim JW, Madsen JR (2018) VEGF signaling in neurological disorders. Int J Mol Sci 19(1):275. https://doi.org/10.3390/ijms19010275

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hua R, Qing L, Wong IYH, Ning H, Wang H (2017) Choroidal microvascular proliferation secondary to diabetes mellitus. Oncotarget 8(2):2034

Article  PubMed  Google Scholar 

Jensen EG, Jakobsen TS, Thiel S, Askou AL, Corydon TJ (2020) Associations between the complement system and choroidal neovascularization in wet age-related macular degeneration. Int J Mol Sci 21(24):9752. https://doi.org/10.3390/ijms21249752

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rong AJ, Swaminathan SS, Vanner EA, Parrish RK II (2022) Predictors of neovascular glaucoma in central. Am J Ophthalmol 204:62–69. https://doi.org/10.1016/j.ajo.2019.02.038

Article  Google Scholar 

Thanigaimani S, Kichenadasse GA, Mangoni A (2011) The emerging role of vascular endothelial growth factor (VEGF) in vascular homeostasis: lessons from recent trials with anti-VEGF drugs. Curr Vasc Pharmacol 9(3):358–380. https://doi.org/10.2174/157016111795495503

Article  CAS  PubMed  Google Scholar 

Wang Y, Yao Y, Li R et al (2023) Different effects of anti-VEGF drugs (Ranibizumab, Aflibercept, Conbercept) on autophagy and its effect on neovascularization in RF/6A cells. Microvasc Res 138:104207. https://doi.org/10.1016/j.mvr.2021.104207

Article  CAS  Google Scholar 

Hashimoto Y, Okada A, Matsui H, Yasunaga H, Aihara M, Obata R (2023) Recent trends in anti-vascular endothelial growth factor intravitreal injections: A large claims database study in Japan. Jpn J Ophthalmol 67(1):109–118. https://doi.org/10.1007/s10384-022-00969-2

Article  CAS  PubMed  Google Scholar 

Hatamnejad A, Dadak R, Orr S, Wykoff C, Choudhry N (2022) Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment. BMJ Open Ophthalmol 8(1):e001205. https://doi.org/10.1136/bmjophth-2022-001205

Article  Google Scholar 

Patel PJ, Villavicencio P, Hanumunthadu D (2023) Systematic review of neovascular age-related macular degeneration disease activity criteria use to shorten, maintain or extend treatment intervals with anti-VEGF in clinical trials: implications for clinical practice. Ophthalmol Ther 12(5):2323–2346. https://doi.org/10.1007/s40123-023-00768-z

Article  PubMed  PubMed Central  Google Scholar 

Sam-Oyerinde OA, Patel PJ (2023) Real-world outcomes of anti-vegf therapy in diabetic macular oedema: barriers to treatment success and implications for low/lower-middle-income countries. Ophthalmol Ther 12(2):809–826. https://doi.org/10.1007/s40123-023-00672-6

Article  PubMed  PubMed Central  Google Scholar 

Yuen YS, Tan GSW, Gan NYA et al (2022) Real-world evidence in the management of diabetic macular edema with intravitreal anti-VEGFs in Asia: a systematic literature review. Clin Ophthalmol 16:3503–3526. https://doi.org/10.1016/j.ejphar.2023.175586

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ninkov A, Frank JR, Maggio LA (2022) Bibliometrics: methods for studying academic publishing. Perspect Med Educ 11:173–176. https://doi.org/10.1007/s40037-021-00695-4

Article  PubMed  Google Scholar 

Roldan-Valadez E, Salazar-Ruiz SY, Rafael I-C et al (2019) Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago journal rank, source-normalised impact per paper, H-index, and alternative metrics. Ir J Med Sci 188:939–951. https://doi.org/10.1007/s11845-018-1936-5

Article  PubMed  Google Scholar 

Kokol P (2023) Discrepancies among Scopus and Web of Science, coverage of funding information in medical journal articles: a follow-up study. J Med Libr Assoc 111:703–708. https://doi.org/10.5195/jmla.2023.1513

Article  PubMed  PubMed Central  Google Scholar 

Arruda H, Silva ER, Lessa M et al (2022) VOSviewer and Bibliometrix. J Med Libr Assoc 110:392–395. https://doi.org/10.5195/jmla.2022.1434

Article  PubMed  PubMed Central  Google Scholar 

Ma W, Xu Z, Wang Q, Zhang Z, Tang D, Zhao J (2023) Metrology and visualization analysis of literatures related to tumor immunotherapy based on CiteSpace. Precision Med Sci 12(3):159–169. https://doi.org/10.1002/prm2.12099

Article  CAS  Google Scholar 

Motlogeloa O, Fitchett JM (2023) Climate and human health: a review of publication trends in the international journal of Biometeorolog. Int J Biometeorol 67(6):933–955. https://doi.org/10.1007/s00484-023-02466-8

Article  PubMed  PubMed Central  Google Scholar 

Díez-Martín F, Blanco-González A, Prado-Román C (2023) The intellectual structure of organizational legitimacy research: a co-citation analysis in business journals. Rev Manag Sci 15(4):1007–1043. https://doi.org/10.1007/s11846-020-00380-6

Article  Google Scholar 

Norris M, Oppenheim C (2010) The h-index: a broad review of a new bibliometric indicator. J Doc 66(5):681–705. https://doi.org/10.1108/00220411011066790

Article  Google Scholar 

Qiu JP, Dong K, Yu HQ (2014) Comparative study on structure and correlation among author co-occurrence networks in bibliometrics. Scientometrics 101:1345–1360. https://doi.org/10.1007/s11192-014-1315-6

Article  Google Scholar 

Belter CW (2015) Bibliometric indicators: opportunities and limits. J Med Libr Assoc JMLA 103(4):219. https://doi.org/10.3163/1536-5050.103.4.014

Article  PubMed  Google Scholar 

Martin DF, Maguire MG, Ying GA, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364(20):1897–1908. https://doi.org/10.1056/nejmoa1102673

Article  CAS  PubMed  Google Scholar 

Heier JS, Brown DM, Chong V et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(12):2537–2548.